The Latest
Rivaroxaban Does Not Reduce VTE Incidence in High-Risk Cancer Patients
Uloric Labeling Updated With New Indication, Boxed Warning After Review of CV Safety Data
Eptinezumab BLA Submitted for Episodic, Chronic Migraine Prevention
Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy
Kratom Exposure in the US Linked to Serious Medical Outcomes
Risk of Tendon Rupture With Fluoroquinolone Use Examined
Early Intensive Treatment May Improve Long-Term MS Outcomes
